Roivant Sciences Stock Number Of Shares Shorted
| ROIV Stock | USD 10.67 0.16 1.48% |
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
Roivant |
Roivant Sciences Company Number Of Shares Shorted Analysis
Roivant Sciences' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Roivant Sciences Number Of Shares Shorted | 42.4 M |
Most of Roivant Sciences' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Roivant Sciences has 42.4 M of outstending shares currently sold short by investors. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The number of shares shorted for all United States stocks is significantly lower than that of the firm.
Roivant Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.Roivant Sciences is currently under evaluation in number of shares shorted category among its peers.
Roivant Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.95) % | ||||
| Operating Margin | (29.22) % | ||||
| Current Valuation | 2.68 B | ||||
| Shares Outstanding | 713.55 M | ||||
| Shares Owned By Insiders | 27.65 % | ||||
| Shares Owned By Institutions | 80.10 % | ||||
| Number Of Shares Shorted | 42.4 M | ||||
| Price To Book | 1.49 X | ||||
| Price To Sales | 63.04 X | ||||
| Revenue | 124.8 M | ||||
| Gross Profit | (469.54 M) | ||||
| EBITDA | 4.31 B | ||||
| Net Income | 4.23 B | ||||
| Cash And Equivalents | 1.94 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 499.75 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 7.21 X | ||||
| Cash Flow From Operations | (765.27 M) | ||||
| Short Ratio | 11.17 X | ||||
| Earnings Per Share | (1.00) X | ||||
| Target Price | 16.0 | ||||
| Number Of Employees | 908 | ||||
| Beta | 1.26 | ||||
| Market Capitalization | 7.73 B | ||||
| Total Asset | 7.22 B | ||||
| Retained Earnings | 576.17 M | ||||
| Working Capital | 6.47 B | ||||
| Net Asset | 7.22 B |
About Roivant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roivant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.